Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | SAGIMET BIOSCIENCES INC SER A SGMT | Blue Owl Capital Holdings LP | 1,673,877 5.460% | 1,673,877 (New Position) | Filing History |
| 2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 4,091,118 8.480% | -1,320,172 (-24.40%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | NUVEEN CHURCHILL DIRECT LENDIN NCDL | Blue Owl Capital Holdings LP | 4,039,552 7.410% | 4,039,552 (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | GENERATION ASIA I ACQ LTD GAQ | Blue Owl Capital Holdings LP | 573,000 7.310% | 573,000 (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | AFRICAN AGRICULTURE HLDGS INC AAGR | Blue Owl Capital Holdings LP | 3,119,625 5.390% | 3,119,625 (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Blue Owl Capital Holdings LP | 5,411,290 7.220% | 5,411,290 (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | AEON BIOPHARMA INC AEON | Blue Owl Capital Holdings LP | 46,406 8.450% | 46,406 (New Position) | Filing History |
| 2024-02-14 9:06 pm Purchase | 2023-12-31 | 13G | ENGENE HLDGS INC ENGN | Blue Owl Capital Holdings LP | 1,234,760 5.320% | 1,234,760 (New Position) | Filing History |
| 2024-02-14 9:05 pm Purchase | 2023-12-31 | 13G | ORCHARD THERAPEUTICS PLC ADS N ORTX | Blue Owl Capital Holdings LP | 15,596,600 6.850% | 15,596,600 (New Position) | Filing History |
| 2024-02-14 9:02 pm Purchase | 2023-12-31 | 13G | REPARE THERAPEUTICS INC RPTX | Blue Owl Capital Holdings LP | 3,122,499 7.410% | 3,122,499 (New Position) | Filing History |
| 2024-02-14 9:01 pm Purchase | 2023-12-31 | 13G | CULLINAN THERAPEUTICS INC CGEM | Blue Owl Capital Holdings LP | 3,419,842 7.990% | 3,419,842 (New Position) | Filing History |
| 2024-02-14 8:57 pm Purchase | 2023-12-31 | 13G | LARIMAR THERAPEUTICS INC LRMR | Blue Owl Capital Holdings LP | 3,414,468 7.780% | 3,414,468 (New Position) | Filing History |
| 2024-02-14 8:56 pm Purchase | 2023-12-31 | 13G | SYROS PHARMACEUTICALS INC SYRS | Blue Owl Capital Holdings LP | 1,493,252 5.740% | 1,493,252 (New Position) | Filing History |
| 2024-02-14 8:55 pm Purchase | 2023-12-31 | 13G | PLIANT THERAPEUTICS INC PLRX | Blue Owl Capital Holdings LP | 3,004,199 5.020% | 3,004,199 (New Position) | Filing History |
| 2024-02-14 8:51 pm Purchase | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | Blue Owl Capital Holdings LP | 1,332,302 6.550% | 1,332,302 (New Position) | Filing History |